1-11 of 11
Authors: Robert E Walker
Sort by
Journal Article
The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak
Mohamed Samai and others
The Journal of Infectious Diseases, Volume 217, Issue suppl_1, 15 June 2018, Pages S6–S15, https://doi.org/10.1093/infdis/jiy020
Published: 18 May 2018
Journal Article
Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola
Olamide D Jarrett and others
The Journal of Infectious Diseases, Volume 217, Issue suppl_1, 15 June 2018, Pages S24–S32, https://doi.org/10.1093/infdis/jiy042
Published: 18 May 2018
Journal Article
A Bovine Parainfluenza Virus Type 3 Vaccine Is Safe and Immunogenic in Early Infancy
Get access
David P. Greenberg and others
The Journal of Infectious Diseases, Volume 191, Issue 7, 1 April 2005, Pages 1116–1122, https://doi.org/10.1086/428092
Published: 01 April 2005
Journal Article
A Randomized, Double-Blinded, Placebo-Controlled Trial of Intermittent Administration of Interleukin-2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus
Get access
Jorge A. Tavel and others
The Journal of Infectious Diseases, Volume 188, Issue 4, 15 August 2003, Pages 531–536, https://doi.org/10.1086/377285
Published: 15 August 2003
Journal Article
Effects of Intermittent Interleukin-2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi-Species Expression
Get access
Joseph A. Kovacs and others
The Journal of Infectious Diseases, Volume 182, Issue 4, October 2000, Pages 1063–1069, https://doi.org/10.1086/315821
Published: 01 October 2000
Journal Article
Interleukin-2 Up-Regulates Expression of the Human Immunodeficiency Virus Fusion Coreceptor CCR5 by CD4+ Lymphocytes In Vivo
Get access
Drew Weissman and others
The Journal of Infectious Diseases, Volume 181, Issue 3, March 2000, Pages 933–938, https://doi.org/10.1086/315303
Published: 01 March 2000
Journal Article
A Randomized Trial of High-versus Low-Dose Subcutaneous Interleukin-2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection
Get access
Richard T. Davey and others
The Journal of Infectious Diseases, Volume 179, Issue 4, April 1999, Pages 849–858, https://doi.org/10.1086/314678
Published: 01 April 1999
Journal Article
Subcutaneous Administration of Interleukin-2 in Human Immunodeficiency Virus Type 1-Infected Persons
Get access
Richard T. Davey and others
The Journal of Infectious Diseases, Volume 175, Issue 4, April 1997, Pages 781–789, https://doi.org/10.1086/513971
Published: 01 April 1997
Journal Article
Inhibition of Immunoreactive Tumor Necrosis Factor-α by a Chimeric Antibody in Patients Infected with Human Immunodeficiency Virus Type 1
Get access
Robert E. Walker and others
The Journal of Infectious Diseases, Volume 174, Issue 1, July 1996, Pages 63–68, https://doi.org/10.1093/infdis/174.1.63
Published: 01 July 1996
Journal Article
Combination Therapy with Didanosine and Interferon-a in Human Immunodeficiency Virus-Infected Patients: Results of a Phase I/II Trial
Get access
Joseph A. Kovacs and others
The Journal of Infectious Diseases, Volume 173, Issue 4, April 1996, Pages 840–848, https://doi.org/10.1093/infdis/173.4.840
Published: 01 April 1996
Journal Article
Use Of Recombinant Soluble Cd4 Pseudomonas Exotoxin, A Novel Immunotoxin, For Treatment Of Persons Infected With Human Immunodeficiency Virus
Get access
Richard T. Davey and others
The Journal of Infectious Diseases, Volume 170, Issue 5, November 1994, Pages 1180–1188, https://doi.org/10.1093/infdis/170.5.1180
Published: 01 November 1994
Advertisement
Advertisement